Skip to main content

Oncology Product Page | GileadPro

P1_Trodelvy_1440x576

HCP resources (TNBC)

Bardia A et al.

Sacitizumab govitecan in Metastatic Triple-Negative Breast Cancer

MoA video

Watch the proposed mechanism of action for TRODELVY

Adverse event management summary

Gain a deeper understanding of the safety profile from TRODELVY and how to manage key adverse events

Dosing guide

Dosing and administration guide for TRODELVY

Patient resources (TNBC)

Patient booklet (English)

Provides patients with FAQs and information in English to support discussions with their healthcare professionals

Patient booklet (Arabic)

Provides patients with FAQs and information in Arabic to support discussions with their healthcare professionals

Patient booklet (Simplified Chinese)

Provides patients with FAQs and information in Simplified Chinese to support discussions with their healthcare professionals

Patient booklet (Traditional Chinese)

Provides patients with FAQs and information in Traditional Chinese to support discussions with their healthcare professionals

Our products

Oncology


TRODELVY

(sacituzumab govitecan)